Global health sciences venture fund

Founded 2016

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 10
Rounds per year 2.00
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Exits 1

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Pharmaceutical
  • Therapeutics
Summary

The main office of represented VC is situated in the Vancouver. The venture was found in North America in Canada.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Global health sciences venture fund, startups are often financed by Quark Venture, Polaris Partners, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Pontifax, Viva Ventures Biotech Group, Total Access Fund.

The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 investment rounds annually.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline SQZ Biotech, Canary Medical, ABAC Therapeutics The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Life Science, Medical.

Read more

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Late Stage Venture
25M15 Mar 2021

CalciMedica

Health Care
Information Technology
Life Science
Late Stage Venture
21M11 Mar 2021 United States, La Jolla

ARTMS

Health Care
Information Technology
Early Stage Venture
19M20 May 2020
Canada, Vancouver

Keros Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
Late Stage Venture
56M04 Mar 2020 United States, " United States"}

EnClear Therapies

Biotechnology
Therapeutics
Early Stage Venture
10M19 Feb 2020 United States, Cambridge

Volastra Therapeutics

Biotechnology
Medical
Seed
12M11 Feb 2020
United States, New York

Eyevensys

Biotechnology
Medical Device
Therapeutics
Early Stage Venture
30M08 Jan 2020 France, Paris

Keros Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
Early Stage Venture
23M08 Jan 2019 United States, " United States"}

Canary Medical

Health Care
Medical
Medical Device
Venture - Series Unknown
10M17 May 2018 Canada, Vancouver

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Global health sciences venture fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: